GLGee W. Lau

Gee W. Lau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gee W. Lau has a total of 254 co-authors. Here are the top co-authors by number of shared publications:

  • Jingjun Lin

    Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA

    9 shared publications
  • Zhizhou Kuang

    Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA

    9 shared publications
  • Shanny Hsuan Kuo

    Department of Pathobiology, College of Veterinary Medicine, University of Illinois Urbana-Champaign

    8 shared publications
  • Luchang Zhu

    Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA

    7 shared publications
  • Myung Whan Oh

    Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA

    7 shared publications
  • Shi Qian Lew

    Department of Pathobiology, University of Illinois Urbana-Champaign

    7 shared publications

Latest Publications

  • Open Access

    Pseudomonas aeruginosa Pyocyanin Increases Airway Mucin Biosynthesis by SIRT1-Mediated FOXA2 Inactivation

    by Woosuk Choi, Beata Kosmider, Gee W. Lau

    The potent redox-cycling Pseudomonas aeruginosa secondary metabolite pyocyanin induces acute and persistent oxidative stress in diseased airways. Pyocyanin promotes goblet cell hyperplasia and metaplasia and exacerbates the mucus burden. Forkhead Box A2 (FOXA2) is a key pioneer factor that governs the transition of airway basal epithelial and club cells to goblet cells by transcriptionally repressing the expression of MUC5AC and MUC5B mucin genes. FOXA2 activity is negatively regulated by Thr156 phosphorylation in various cell types. However, how post-translational modifications modulate the transcriptional repression of FOXA2 on airway mucin genes remains uncharacterized. Here, we demonstrate that the interaction between SIRT1 and FOXA2 is significantly increased within pyocyanin-exposed MUC5AC-expressing human bronchial epithelial cells, and in human COPD and pyocyanin-exposed mouse lungs. Pyocyanin promotes SIRT1-mediated deacetylation of FOXA2, which serves as a prerequisite for subsequent phosphorylation, inactivation, and MUC5AC derepression. Specifically, under pyocyanin-imposed oxidative stress, SIRT1 deacetylates FOXA2 at Lys259, which dictates phosphorylation at Thr156, leading to nuclear exclusion, ubiquitination, and proteasome-mediated degradation, initiating airway goblet cell transdifferentiation. By contrast, inactivation of SIRT1 by transient knockdown and chemical inhibition impedes pyocyanin-induced FOXA2 phosphorylation and MUC5AC expression. Our results uncover a novel role of SIRT1 in regulating FOXA2 expression dynamics governing airway mucus homeostasis.

  • Open Access

    Coenzyme Q9 Derived from Oudemansiella raphanipes Attenuates Mucin Biosynthesis Induced by Pseudomonas aeruginosa Pyocyanin in Human Bronchial Epithelial Cells

    by Gun-Do Kim, Min-Jae Kang, Keun Ki Kim, Woosuk Choi, Gee W. Lau

    Pyocyanin is a potent redox-cycling secondary metabolite secreted by the respiratory pathogen Pseudomonas aeruginosa. During chronic P. aeruginosa infections, pyocyanin induces persistent oxidative stress in airway epithelial cells, ultimately leading to goblet cell hyperplasia and metaplasia alongside mucus hypersecretion. Because PCN triggers a redox imbalance by rapid depletion of host antioxidants, restoring cellular antioxidative capacity is essential to mitigate its pathophysiology. Herein, we demonstrate that Coenzyme Q9 (CoQ9) from the edible mushroom Oudemansiella raphanipes attenuates pyocyanin-induced mucus hypersecretion in primary human bronchial epithelial cells by restoring mitochondrial integrity to alleviate oxidative stress. CoQ9 pretreatment attenuates MUC5AC and MUC5B mucin expression by inactivating mucin-promoting signaling cascades, including the EGFR-AKT/ERK1/2 and STAT6-SPDEF axes. In addition to its reactive oxygen species scavenging properties, CoQ9 significantly downregulated pyocyanin-induced mitochondrial superoxide generation by restoring the SIRT3-SOD2 axis. Specifically, CoQ9 pretreatment improved mitochondrial integrity by preserving PINK1-mediated mitophagy and enhancing mitochondrial biogenesis through activation of the AMPK-PGC1α axis, thereby restoring ATP levels under PCN exposure.

  • Open Access

    Semaglutide and pioglitazone restore airway mucosal homeostasis by resolving Pseudomonas aeruginosa pyocyanin-induced mucus hypersecretion, ciliostasis, and type 2 airway inflammation

    by Cong Wu, Nitish A. Kulkarni, Shi Qian Lew, Woosuk Choi, Mayandi Sivaguru, Beata Kosmider, Som G. Nanjappa, Gee W. Lau

    Rationale: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. As lung transplantation is the only curative option and current therapies are largely based on managing clinical symptoms, novel treatments are urgently needed. Objective: Previously, we showed that the first-generation incretin Exedine-4 could attenuate airway mucus dysregulation induced by the Pseudomonas aeruginosa redox-active toxin pyocyanin by modulating GLP1R-PPARγ signaling. In this study, we compared the efficacy of currently approved next-generation GLP1R agonists and PPARγ agonists in improving airway mucus homeostasis, mucociliary escalator function, and P . aeruginosa clearance after chronic exposure to pyocyanin, as well as the underlying mechanisms. Methods: Six GLP-1R agonists and two PPARγ agonists were compared based on their ability to attenuate pyocyanin-induced oxidative stress and mucin overexpression in 16HBE14o− cells by the cellular reactive oxygen species (ROS) assays, immunoblotting, and confocal immunofluorescence microscopy. The ability of these agonists to restore the mucociliary escalator function in air-liquid interface (ALI) cultures of primary human small airway epithelial cells (SAECs) was captured by confocal immunofluorescence microscopy. Then, we examined whether these agonists could restore mucus homeostasis, neutralize lung proinflammatory responses, and reduce bacterial burden in C57BL/6 mice. Finally, the expression of relevant pro- and anti-mucin biosynthesis signaling pathways was investigated. Measurements and main results: Semaglutide and Pioglitazone are the most effective in decreasing the expression of mucus biomarker MUC5AC mucin and ROS production in response to pyocyanin, both in vitro and in vivo . Additionally, these agonists restore mucociliary beat frequency and mucociliary transport impaired by pyocyanin. The protective effects of these drugs were partially abolished by respective antagonists, Exendin(9-39) and GW9662, against GLP1R and PPARγ, confirming the GLP1R signaling pathway-dependent mechanisms. Moreover, Semaglutide and Pioglitazone also attenuated type 2 immune responses and neutrophil influx, both of which are known drivers of mucus hypersecretion, and reduced the P. aeruginosa burden in a chronic bronchitis model of infection in mouse lungs. Conclusions: Our findings identify a promising adjunctive therapeutic avenue for COPD by repurposing FDA-approved Semaglutide and Pioglitazone, which are readily available for clinical use.

  • Open Access

    Pseudomonas aeruginosa-derived volatile organic compounds modulate host immunity to disrupt airway mucus homeostasis

    by Shanny Hsuan Kuo, Jaishree Sharma, Cong Wu, Miranda D. Vieson, Beata Kosmider, Scott H. Randell, Som G. Nanjappa, Gee W. Lau

    Chronic pulmonary diseases, including cystic fibrosis, chronic obstructive pulmonary disease, and chronic bronchitis, as well as ventilator-associated pneumonia, are characterized by persistent infection of mucus-laden airways. Pseudomonas aeruginosa (PA) is a dominant pathogen in these conditions and produces volatile organic compounds (VOCs) that have been proposed as biomarkers of disease exacerbation; however, their immunopathogenic roles remain unclear. We investigated PA-derived VOCs using human bronchial epithelial air–liquid interface cultures and murine models. VOCs exposure significantly increased airway mucin expression and induced a proinflammatory response characterized by M1 macrophage polarization (iNOS + ), neutrophil recruitment, and expansion of IL-17A–producing Thy1.2 + lymphocytes. Functional depletion of macrophages, neutrophils, or IL-17A in vivo each attenuated mucin production and goblet cell metaplasia, indicating non-redundant contributions to mucus pathology. In vitro , IL-17A neutralization partially restored FOXA2 expression and reduced mucin production, supporting a role in mucus regulation. On the mechanistic level, we discovered an IL-17A-dependent dual-axis pathway involving both epithelial cell-mediated autocrine and lymphocyte-mediated paracrine signaling that contributes to the feed-forward loop of inflammation and enhances the signaling pathways regulating mucus hypersecretion in airways. We conclude that PA VOCs activate multiple proinflammatory responses to convergently drive mucus pathogenesis in the diseased lung.

  • Fatty Acid Biosynthesis Inhibitors─Fabimycin and Triclosan─Trigger Distinct Resistance Mutations in FabI and Potently Kill Gram-Negative Pathogens

    by Brett N. Cain, James E. Kent, Marinela Elane, John D. Williams, Myung Ryul Lee, Gee W. Lau, Paul J. Hergenrother, Andrei L. Osterman

    In an effort to develop efficacious antibacterials that engage targets for which there is no preexisting resistance, inhibition of the enoyl-acyl carrier protein reductase FabI has shown promise, with triclosan and fabimycin as representative members of the two major drug classes that show activity against important bacterial pathogens. Here, we use a morbidostat and whole-genome sequencing approach to comprehensively evaluate the resistance profiles that arise in pathogenic bacteria in response to these FabI inhibitors. When assessed against E. coli, fabimycin and triclosan were found to induce primarily nonoverlapping resistance profiles, leading to minimal cross-resistance between the two compounds. Furthermore, in vivo evaluation of the prominent resistant mutants indicates poor fitness, with the fittest mutant still susceptible to fabimycin. Collectively, these results suggest the combination use of two antibiotics that engage different positions on the same target as a means to kill pathogenic bacteria and limit resistance.

  • Open Access

    Pseudomonas aeruginosa-derived volatile organic compounds modulate AhR signaling to dysregulate airway mucus homeostasis

    by Shanny Hsuan Kuo, Shi Qian Lew, Sook Yin Chong, Cong Wu, Allison B. Williams, Beata Kosmider, Scott H. Randell, Laurence G. Rahme, Gee W. Lau

    Pseudomonas aeruginosa frequently infects chronically diseased lungs and exacerbates airway mucus hypersecretion and failure in clearance. P. aeruginosa is metabolically versatile and secretes multiple volatile organic compounds (VOCs), which have been scrutinized as potential biomarkers for diagnosing acute exacerbation in diseased lungs. However, the pathogenic roles of VOCs in mucus dysregulation are unknown. By using air-liquid interface cultures of normal and diseased human bronchial epithelial cells and a mouse model of chronic VOCs exposure, we report that dominant species of P. aeruginosa VOCs in concentrations found in both the breath of cystic fibrosis patients and in the headspace of bacterial cultures significantly elevated the expression of the mucin MUC5AC. VOCs activate the AhR signaling to inhibit FOXA2, a key regulator of airway mucus homeostasis. AhR inhibitor restored FOXA2 expression to attenuate excessive mucin expression. Mechanistic studies revealed that P. aeruginosa VOCs activate the AhR-ARNT-CYP1-ROS signaling cascade, which in turn induces the EGFR-AKT/ERK signaling pathways to disrupt airway mucus homeostasis. Taken together, these findings highlight the critical role of P. aeruginosa VOCs in disrupting airway mucus homeostasis and implicate the pathogenic role of AhR signaling in chronic lung diseases.


  • Open Access

    A synopsis of competence-regulated virulence in Streptococcus pneumoniae

    by Sook Yin Chong, Shi Qian Lew, Gee W. Lau

    Streptococcus pneumoniae (pneumococcus) remains a significant cause of pneumonia, bacteremia, sepsis, meningitis, and otitis media. The ability of pneumococcus to enter a state of genetic competence is central to pneumococcal adaptability and virulence. Activation of the competence state enables pneumococcus to uptake exogenous DNA for genetic transformation, acquire genome plasticity and antimicrobial resistance, while also regulating stress tolerance, biofilm formation, and coordinated expression of virulence factors. This review summarizes current evidence on competence-regulated virulence across diverse infection models, including nasopharyngeal colonization, otitis media, meningitis, bacteremia, and pneumonia, highlighting how the competence regulon impacts pneumococcal host colonization, invasion, and disease progression. Comparative insights into pneumococcal competence in vitro versus in vivo are provided to highlight context-dependent regulation of disease progression. Finally, this review examines emerging competence regulon-targeted therapeutic strategies, including dominant-negative competence-stimulating peptides and inhibitors of competence induction, which have been shown to suppress transformation and attenuate pneumococcal virulence.


  • Open Access

    Synergistic interactions between Bacteroides intestinalis and Arabinoxylan Mitigates Inflammatory and Metabolic Dysfunction

    by Ziyu Zhou, Ka Lam Nguyen, Sijie Chen, Yuexi Wang, Min Li, David M. Bianchi, Weihao Ge, Shanny Hsuan Kuo, Salwa Gharieb, Emily Tung, et al.

    Insufficient dietary fiber intake is closely linked to gut microbiome dysfunction and increased risk of noncommunicable diseases. Synergistic synbiotics, pairing defined microbes with their dietary substrates, offer a precise strategy to restore microbiome function. Here, we show that pairing the human colonic commensal Bacteroides intestinalis with insoluble wheat arabinoxylan (inWAX) yields pronounced metabolic and anti-inflammatory benefits. Using mono-associated gnotobiotic mice and high-fat diet-induced obese mice, we demonstrate that this synbiotic enhances resistance to intestinal inflammation and improves glucose homeostasis. Mechanistically, this synbiotic increases production of 6-hydroxylated bile acids with anti-diabetic and anti-steatotic effects. It also promotes microbial transformation of phenolic compounds and redirects protein metabolism toward neuroactive metabolites. These metabolic shifts are accompanied by transcriptional remodeling in the colon, spleen and liver, involving induction of genes essential for circadian rhythm, lipid metabolism, immune defense, and bile acid 6-hydroxylation. Notably, Y chromosome-linked genes associated with epigenetic regulation and protein turnover are also induced, suggesting a potential sex-specific response to synbiotics. Together, our findings establish a mechanistic framework for targeted synbiotic interventions to combat inflammatory and metabolic disorders.

  • Open Access

    Pseudomonas aeruginosa-derived metabolites and volatile organic compounds: impact on lung epithelial homeostasis and mucosal immune response

    by Shanny Hsuan Kuo, Gee W. Lau

    Pulmonary diseases, such as cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and ventilator-associated pneumonia (VAP), are attributed to the prolonged infection of the airway and hypersecretion of mucus. Pseudomonas aeruginosa (PA) is one of the most common nosocomial pathogens in these diseased airways, secreting a wide spectrum of metabolites and volatile organic compounds (VOCs) that significantly impact the respiratory epithelium, including disruption of mucus homeostasis and inflammatory responses of the diseased lungs. In this review, we highlighted the major metabolites and VOCs produced by PA and the mechanisms by which they modulate inflammation, cellular injury, and mucus hypersecretion in respiratory epithelium.


  • Open Access

    Corrigendum: Modulation of pulmonary immune functions by the Pseudomonas aeruginosa secondary metabolite pyocyanin

    by Shi Qian Lew, Sook Yin Chong, Gee W. Lau

    Corrigendum: Modulation of Pulmonary Immune Functions by the Pseudomonas aeruginosa Secondary Metabolite PyocyaninName of all authors as they appear in the published original article (INSERT ONLY IF correcting author names or adding authors. Insert the correct version of the author list)Affiliations of all authors as they appear in the published original version of the article (INSERT ONLY IF correcting affiliation(s) or adding affiliation(s). Insert the correct version of the affiliation(s))* Correspondence: geelau@illinois.eduKeywords: Pseudomonas aeruginosa, pyocyanin, reactive oxygen and nitrogen species, oxidative stress, immune modulation, chronic lung diseasesCorrigendum on: Incorrect ReferenceIn the published article, the reference for [39] was incorrectly written as Thees A, Tan M-W, Le L, Wong SM, Tompkins RG, Calderwood SB, et al. PmtA regulates pyocyanin expression and biofilm formation in Pseudomonas aeruginosa. Front Microbiol. (2021) 12:789765. doi: 10.3389/fmicb.2021.789765. It should be Thees, A., Pietrosimone, K., Melchiorre, C., Marden, J., Graf, J., Lynes, M. et al. PmtA regulates pyocyanin expression and biofilm formation in Pseudomonas aeruginosa. Front Microbiol 12: 789765. (2021). https://doi.org:10.3389/fmicb.2021.789765. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.